Cellular regeneration via pluripotency

Cellular regeneration via pluripotency is not a specific molecule or receptor but rather describes the biological process by which mature somatic cells are reverted to a pluripotent state—capable of differentiating into any cell type—through the induction of defined transcription factors. This process underlies the creation of induced pluripotent stem cells (iPSCs), typically achieved by introducing genes such as Oct3/4 (POU5F1), Sox2, Klf4, and c‑Myc. These factors orchestrate widespread epigenetic changes including promoter demethylation and histone modification that reactivate genes associated with embryonic stem cell identity. The resulting iPSCs closely resemble embryonic stem cells in their gene expression and differentiation potential. While this technology has transformative implications for regenerative medicine and disease modeling, it is not itself a discrete therapeutic target like an enzyme or receptor; rather it is mediated by several molecular targets—primarily transcription factors—and involves complex cellular pathways.

Other names

Induced pluripotencyPluripotent stem cell reprogrammingiPSC generationCellular reprogramming

Induction of transcription factors to revert somatic cells to a pluripotent state